Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

This study is not yet open for participant recruitment. (see Contacts and Locations)
Verified May 2013 by Massachusetts General Hospital
Sponsor:
Information provided by (Responsible Party):
Albert Yeung, Massachusetts General Hospital
ClinicalTrials.gov Identifier:
NCT01851967
First received: January 8, 2013
Last updated: May 13, 2013
Last verified: May 2013
  Purpose

This study aims to evaluate efficacy and acceptability of the Chinese language version of MoodGYM as a therapeutic intervention in treating symptoms of depression in community dwelling Chinese Americans in the Boston area.

Hypothesis 1: Participants enrolled in MoodGYM will show a significant decrease in depressive symptoms after completion of the 5 modules.

Hypothesis 2: Participants enrolled in MoodGYM will show significantly improved dysfunctional thinking.

Hypothesis 3: Participants enrolled in MoodGym will rate this program as culturally acceptable.


Condition Intervention
Major Depressive Disorder
Other: MoodGYM

Study Type: Interventional
Study Design: Endpoint Classification: Efficacy Study
Intervention Model: Single Group Assignment
Masking: Open Label
Primary Purpose: Treatment
Official Title: Effectiveness and Acceptability of MoodGYM in Treating Depressive Symptoms in Chinese Americans

Resource links provided by NLM:


Further study details as provided by Massachusetts General Hospital:

Primary Outcome Measures:
  • Change in Center for Epidemiologic Studies Depression Scale (CES-D) [ Time Frame: Weeks 0, 6 (pre/post) ] [ Designated as safety issue: No ]
    The CES-D scale is a short self-report scale designed to measure depressive symptomatology in the general population. Each of the 20 items in this instrument is assigned one value of 0, 1, 2 or 3. High scores on the CES-D indicate high levels of distress.


Estimated Enrollment: 60
Study Start Date: September 2013
Estimated Primary Completion Date: February 2014 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
Experimental: MoodGYM
This study is a single-arm intervnetion. All subjects will be assigned to receive six weeks of online CBT through MoodGYM.
Other: MoodGYM
MoodGYM, a publicly-available online CBT program developed by the Centre for Mental Health Research at The Australian National University has been shown by multiple studies to be effective in reducing symptoms of depression. MoodGYM consists of five interactive modules. Participants will be asked to complete one module each week and progress through the program sequentially.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Resident of the US, but self-identified as Chinese origin
  • At least 18 years of age
  • Proficiency in Chinese, including the ability to read Chinese
  • Access to computer and internet
  • Scores > 10 on the Chinese bilingual patient health questionnaire -9 item (PHQ-9)

Exclusion Criteria:

  • Current ongoing psychiatric or psychological treatment
  • Using illicit drugs or consumption > 3 standard drinks in a day
  • Currently experiencing a psychotic illness
  • Past or current history of schizophrenia or bipolar disorder
  • ECT during the last year
  • Current active suicidal or self-injurious potential necessitating immediate face-to-face treatment
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT01851967

Contacts
Contact: Albert Yeung, MD, ScD 617-724-5138 ayeung@partners.org
Contact: Aya Inamori, BA 617-724-0586 ainamori@partners.org

Locations
United States, Massachusetts
Massachusetts General Hospital Depression Clinical and Research Program Not yet recruiting
Boston, Massachusetts, United States, 02114
Contact: Angela Pisoni, BA    617-726-0517    apisoni@partners.org   
Principal Investigator: Albert Yeung, MD, ScD         
Sponsors and Collaborators
Massachusetts General Hospital
  More Information

Additional Information:
No publications provided

Responsible Party: Albert Yeung, Principle Investigator / Psychiatrist, Massachusetts General Hospital
ClinicalTrials.gov Identifier: NCT01851967     History of Changes
Other Study ID Numbers: 2012-P-002340
Study First Received: January 8, 2013
Last Updated: May 13, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by Massachusetts General Hospital:
Major depressive disorder
Cognitive behavioral therapy
Computerized CBT
Online CBT

Additional relevant MeSH terms:
Depressive Disorder
Depression
Depressive Disorder, Major
Mood Disorders
Mental Disorders
Behavioral Symptoms

ClinicalTrials.gov processed this record on July 22, 2014